CD4 and neoplasm: Sutterwala et al. demonstrated that NLRC4 enhanced inflammation in tumor-associated macrophages (TAMs) in a noninflammasome-dependent manner and the antimelanoma effects of IFN-γ produced by CD4 + and CD8 + T cells (Janowski et al., 2016).